Beranda › Kanker Ovarium › North Carolina › Charlotte
Uji klinis Kanker Ovarium di Charlotte, NC
12 studi untuk Kanker Ovarium mencari peserta di lokasi sekitar Charlotte (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Menerima pesertaFase 1
- Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville · 13 mi jauhnya
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Menerima pesertaFase 2
- Atrium Health Levine Cancer Institute /ID# 274557, Charlotte
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Menerima pesertaFase 3
- Levine Cancer Center, Charlotte
- Novant Presbyterian Hospital, Charlotte
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Menerima pesertaFase 1/2
- Research Site, Charlotte
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Menerima pesertaFase 3
- Levine Cancer Institute, Charlotte
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Menerima pesertaFase 1
- Atrium Health - Wake Forest, Charlotte
A Study of DM002 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Carolina BioOncology Institute, LLC, Huntersville · 13 mi jauhnya
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Clinical Trial Site, Huntersville · 13 mi jauhnya
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Menerima pesertaFase 2
- GSK Investigational Site, Charlotte
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi jauhnya
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Menerima pesertaFase 1/2
- Levine Cancer Institute (LCI)- Atrium Health, Charlotte
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Menerima pesertaFase 1
- Dren Investigational Site, Huntersville · 13 mi jauhnya
Uji klinis Kanker Ovarium di kota lain
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Studi lain di Charlotte
- Kanker (semua jenis)27 studi
- Kanker Payudara22 studi
- Mieloma Multipel21 studi
- Kanker Paru Non-Sel Kecil19 studi
- Leukemia Mieloid Akut16 studi
- Obesitas16 studi
- Kelebihan Berat Badan15 studi
- Kanker Kolorektal13 studi
- Gagal Jantung11 studi
- Kanker Metastatik11 studi
- Karsinoma Sel Skuamosa Kepala dan Leher10 studi
- PPOK9 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.